# High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

> **NCT04024527** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 306 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Amoxicillin
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT04024527
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-25
- **Primary completion:** 2021-04-12
- **Final completion:** 2021-05-24
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04024527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04024527, "High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04024527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*